CTEV vs EHTH

For growth investors, eHealth, Inc.

(EHTH) is the stronger pick with 4. 1% revenue growth year-over-year, versus 3. 7% for Claritev Corporation (CTEV). Analysts rate Claritev Corporation (CTEV) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

Over the past 5 years, Claritev Corporation (CTEV) delivered a total return of +0.

8%, compared to -97. 3% for eHealth, Inc. (EHTH). Over 10 years, the gap is even starker: CTEV returned +0. 8% versus EHTH's -88. 3%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), eHealth, Inc.

(EHTH) is the lower-risk stock at 1. 68β versus Claritev Corporation's 2. 26β — meaning CTEV is approximately 35% more volatile than EHTH relative to the S&P 500.

By revenue growth (latest reported year), eHealth, Inc.

(EHTH) is pulling ahead at 4. 1% versus 3. 7% for Claritev Corporation (CTEV). On earnings-per-share growth, the picture is similar: Claritev Corporation grew EPS 83. 0% year-over-year, compared to 71. 4% for eHealth, Inc.. Over a 3-year CAGR, EHTH leads at 11. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

eHealth, Inc.

(EHTH) is the more profitable company, earning 7. 2% net margin versus -29. 4% for Claritev Corporation — meaning it keeps 7. 2% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: EHTH leads at 12. 4% versus 4. 7% for CTEV. At the gross margin level — before operating expenses — EHTH leads at 97. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

In this comparison, EHTH (11.

7% yield) pays a dividend. CTEV does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, eHealth, Inc.

(EHTH) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (11. 7% yield). Claritev Corporation (CTEV) carries a higher beta of 2. 26 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (EHTH: -88. 3%, CTEV: +0. 8%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (CTEV (Healthcare) and EHTH (Financial Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: CTEV is a small-cap quality compounder stock; EHTH is a small-cap income-oriented stock. EHTH pays a dividend while CTEV does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.